<SEC-DOCUMENT>0000950170-23-011363-index.html : 20230331
<SEC-HEADER>0000950170-23-011363.hdr.sgml : 20230331
<ACCEPTANCE-DATETIME>20230331160423
ACCESSION NUMBER:		0000950170-23-011363
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20230331
DATE AS OF CHANGE:		20230331

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Virax Biolabs Group Ltd
		CENTRAL INDEX KEY:			0001885827
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270734
		FILM NUMBER:		23787481

	BUSINESS ADDRESS:	
		STREET 1:		30 BROADWICK STREET
		CITY:			LONDON
		STATE:			X0
		ZIP:			W1F 8LX
		BUSINESS PHONE:		44 020 7788 7414

	MAIL ADDRESS:	
		STREET 1:		30 BROADWICK STREET
		CITY:			LONDON
		STATE:			X0
		ZIP:			W1F 8LX

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Virax Biolabs (Cayman) Ltd
		DATE OF NAME CHANGE:	20210930
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>424b3_march_2023_pipe.htm
<DESCRIPTION>424B3
<TEXT>
Document 1 - file: 424b3_march_2023_pipe.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>img113891770_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: img113891770_0.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img113891770_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: img113891770_1.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img113891770_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: img113891770_2.jpg

</DOCUMENT>
</SEC-DOCUMENT>